Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1954 1
1955 1
1959 1
1961 2
1962 1
1969 1
1970 1
1973 1
1975 3
1976 2
1977 2
1978 3
1979 5
1980 4
1981 4
1982 3
1983 2
1984 6
1985 6
1986 4
1987 7
1988 7
1989 14
1990 10
1991 13
1992 10
1993 19
1994 21
1995 17
1996 22
1997 16
1998 19
1999 20
2000 22
2001 21
2002 20
2003 24
2004 35
2005 53
2006 53
2007 41
2008 43
2009 33
2010 41
2011 35
2012 34
2013 39
2014 42
2015 42
2016 44
2017 55
2018 48
2019 56
2020 61
2021 61
2022 55
2023 51
2024 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,199 results

Results by year

Filters applied: . Clear all
Page 1
Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial.
van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes Cerisuelo M, Darwish Murad S, Erdmann JI, Gilbo N, de Haas RJ, Heaton N, van Hoek B, Huurman VAL, Jochmans I, van Leeuwen OB, de Meijer VE, Monbaliu D, Polak WG, Slangen JJG, Troisi RI, Vanlander A, de Jonge J, Porte RJ; DHOPE-DCD Trial Investigators. van Rijn R, et al. Among authors: van den berg ap. N Engl J Med. 2021 Apr 15;384(15):1391-1401. doi: 10.1056/NEJMoa2031532. Epub 2021 Feb 24. N Engl J Med. 2021. PMID: 33626248 Clinical Trial.
Prolonged hypothermic machine perfusion enables daytime liver transplantation - an IDEAL stage 2 prospective clinical trial.
Brüggenwirth IMA, Lantinga VA, Lascaris B, Thorne AM, Meerdink M, de Kleine RH, Blokzijl H, van den Berg AP, Reyntjens KMEM, Lisman T, Porte RJ, de Meijer VE; DHOPE-PRO Trial Investigators. Brüggenwirth IMA, et al. Among authors: van den berg ap. EClinicalMedicine. 2024 Jan 5;68:102411. doi: 10.1016/j.eclinm.2023.102411. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38235423 Free PMC article.
Organs-on-chips: breaking the in vitro impasse.
van der Meer AD, van den Berg A. van der Meer AD, et al. Among authors: van den berg a. Integr Biol (Camb). 2012 May;4(5):461-70. doi: 10.1039/c2ib00176d. Epub 2012 Mar 5. Integr Biol (Camb). 2012. PMID: 22388577 Review.
Microfluidic organ-on-chip technology for blood-brain barrier research.
van der Helm MW, van der Meer AD, Eijkel JC, van den Berg A, Segerink LI. van der Helm MW, et al. Among authors: van den berg a. Tissue Barriers. 2016 Jan 28;4(1):e1142493. doi: 10.1080/21688370.2016.1142493. eCollection 2016 Jan-Mar. Tissue Barriers. 2016. PMID: 27141422 Free PMC article. Review.
Human ego-motion perception.
van den Berg AV. van den Berg AV. Int Rev Neurobiol. 2000;44:3-25. doi: 10.1016/s0074-7742(08)60735-7. Int Rev Neurobiol. 2000. PMID: 10605639 Review. No abstract available.
SETD2: an epigenetic modifier with tumor suppressor functionality.
Li J, Duns G, Westers H, Sijmons R, van den Berg A, Kok K. Li J, et al. Among authors: van den berg a. Oncotarget. 2016 Aug 2;7(31):50719-50734. doi: 10.18632/oncotarget.9368. Oncotarget. 2016. PMID: 27191891 Free PMC article. Review.
1,199 results